Lava Medtech Acquisition Stock Profit Margin
| LVACDelisted Stock | USD 10.44 0.00 0.00% |
LAVA Medtech Acquisition fundamentals help investors to digest information that contributes to LAVA Medtech's financial success or failures. It also enables traders to predict the movement of LAVA Stock. The fundamental analysis module provides a way to measure LAVA Medtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LAVA Medtech stock.
LAVA |
LAVA Medtech Acquisition Company Profit Margin Analysis
LAVA Medtech's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, LAVA Medtech Acquisition has a Profit Margin of 0.0%. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
LAVA Fundamentals
| Return On Asset | -0.0081 | |||
| Current Valuation | 144.92 M | |||
| Shares Outstanding | 11.5 M | |||
| Shares Owned By Institutions | 92.16 % | |||
| Number Of Shares Shorted | 6.82 K | |||
| Price To Book | 1.27 X | |||
| EBITDA | (6.22 M) | |||
| Net Income | 4.5 M | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 92.81 K | |||
| Debt To Equity | 4.92 % | |||
| Current Ratio | 18.29 X | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (658.82 K) | |||
| Short Ratio | 0.08 X | |||
| Earnings Per Share | 0.31 X | |||
| Market Capitalization | 149.93 M | |||
| Total Asset | 120.67 M | |||
| Retained Earnings | (3.01 M) | |||
| Working Capital | (3.39 M) | |||
| Net Asset | 120.67 M |
About LAVA Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LAVA Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LAVA Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LAVA Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in LAVA Stock
If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |